angiotensin ii, des-phe(8)- has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, X; Pan, D; Qin, Y; Wang, S; Wang, X; Wu, C; Xu, S; Xu, X; Ye, G | 1 |
| Chen, Y; Hao, P; Li, B; Li, G; Liu, Y; Shang, R; Wang, J; Wang, X; Yang, J; Zhang, C; Zhang, M; Zhang, Y | 1 |
2 other study(ies) available for angiotensin ii, des-phe(8)- and Hepatocellular Carcinoma
| Article | Year |
|---|---|
The association of renin-angiotensin system genes with the progression of hepatocellular carcinoma.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Antigens, CD34; Biomarkers, Tumor; Carcinoma, Hepatocellular; Case-Control Studies; Gene Expression Regulation, Neoplastic; Humans; Liver Cirrhosis; Liver Neoplasms; Peptide Fragments; Peptidyl-Dipeptidase A; Prognosis; Reference Values; Renin-Angiotensin System; Vascular Endothelial Growth Factor A | 2015 |
Angiotensin-(1-7) Suppresses Hepatocellular Carcinoma Growth and Angiogenesis via Complex Interactions of Angiotensin II Type 1 Receptor, Angiotensin II Type 2 Receptor and Mas Receptor.
Topics: Angiotensin I; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mitogen-Activated Protein Kinase 11; Neovascularization, Pathologic; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Xenograft Model Antitumor Assays | 2015 |